Simvastatine

Quick links to important sections

Simvastatine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Simvastatine

The following table provides a quick, factual overview of Simvastatin.

Property Description
Active ingredient Simvastatin
Form Oral Tablet
Pharmacological class HMG-CoA Reductase Inhibitor (Statin)
Common use Reducing high cholesterol (LDL-C)
Origin Semi-synthetic

What Type of Medicine is Simvastatin?

Simvastatin is classified as a potent antilipemic agent that belongs to the statin class, formally known as HMG-CoA Reductase Inhibitors. This medicine is a semi-synthetic derivative designed for oral administration as a single-ingredient product in tablet form. It is designated as a first-line therapy for managing abnormal blood lipid levels, a use clinically recognized by major international guidelines.

Its identity as a statin is crucial because this class is distinct from other lipid-lowering agents, targeting the internal production of lipids rather than their absorption. The fact that Simvastatin is a well-established generic option makes it a widely accessible choice for patients requiring long-term treatment.


Composition, Form, and General Purpose

The active ingredient is Simvastatin, which is administered in its inactive lactone structure. This means the drug functions as a prodrug that requires metabolic activation by the liver before it can exert its therapeutic effect. The compound's semi-synthetic origin ensures efficient delivery to the liver, the key site of its action.

The overarching purpose of Simvastatin is to significantly lower elevated levels of cholesterol, specifically Low-Density Lipoprotein Cholesterol (LDL-C). This therapeutic action aims for the primary prevention of cardiovascular disease and is typically used where an adult patient requires long-term management of high cholesterol to minimize future cardiac risk. By consistently reducing this bad cholesterol, the drug supports overall heart and blood vessel health.

What side effects are possible with Simvastatine?

Possible side effects and safety information

The safety profile of Simvastatin is formally established through regulatory classifications, grouping documented adverse reactions by frequency and affected physiological systems. The primary safety concerns noted in official labeling relate to potential effects on the musculoskeletal and hepatobiliary systems.

Adverse Reaction Classification

Adverse reactions are classified using standard regulatory frequency categories, such as Rare (ge 1/10,000 to < 1/1,000), Very Rare (< 1/10,000), and Not Known (frequency cannot be estimated from available data).

System-Organ Class (SOC) Examples of Documented Adverse Reactions
Musculoskeletal Myopathy, Myalgia, Rhabdomyolysis
Hepatobiliary Hepatitis, Jaundice, Elevated Transaminases
Nervous System Headache, Dizziness, Memory Impairment
Gastrointestinal Constipation, Abdominal Pain, Flatulence

Serious Safety Considerations

Regulatory documents highlight serious adverse reactions including Rhabdomyolysis (a severe form of muscle breakdown) and rare instances of fatal and non-fatal Hepatic Failure. Reports of Immune-Mediated Necrotizing Myopathy (IMNM) and Hypersensitivity Syndrome are also documented.

Population and Dose-Related Constraints

The official labeling notes several high-level safety constraints. Simvastatin is contraindicated in patients with active liver disease and during pregnancy or breastfeeding. The risk of muscle injury is explicitly documented as dose-dependent, increasing with higher dosage levels and when used concomitantly with certain medicines that inhibit the CYP3A4 enzyme. Furthermore, an increased risk of myopathy is noted for patients of Chinese descent, and specific dose restrictions apply to the highest strengths of the medicine.

Overdose and Emergency Response

Simvastatine Overdose and When to Seek Help

The regulatory information concerning acute overdosage with Simvastatine is highly specific and centers on required emergency response rather than detailed clinical manifestations. Official drug labels indicate that no specific antidotes are known for Simvastatine. Consequently, the management of overdosage is defined as generally involving symptomatic and supportive treatment based on the patient's clinical presentation.

No specific clinical signs, symptoms, or laboratory abnormalities resulting from acute human overdosage have been formally documented or consistently reported in the regulatory prescribing information. Furthermore, no specific severity classification for overdosage (e.g., mild, moderate, severe) is defined, nor are population-based considerations for subgroups, such as elderly or renally impaired patients, explicitly listed in the official overdosage summary.

Immediate action is required if an overdosage is suspected or confirmed. Regulatory authorities mandate that specialized professional guidance be sought immediately. Specifically, the official guidance instructs the patient or caregiver to contact a poison control center or equivalent emergency medical services for the latest recommendations on management and to guide appropriate supportive care. This mandated action remains the primary regulatory instruction, emphasizing the need for urgent professional assessment due to the lack of a known specific reversal agent.

Therapeutic Uses of Simvastatine

Main uses of Simvastatine

Simvastatine belongs to a group of medications known as statins. It is primarily used to manage lipid levels in the blood, specifically focusing on cholesterol and triglycerides. The medication is typically prescribed when dietary changes, weight loss, and exercise alone have not been sufficient to reach target lipid levels.

Cholesterol Management

Simvastatine is used to lower high levels of total cholesterol and "bad" cholesterol, known as Low-Density Lipoprotein (LDL) cholesterol. By reducing the production of cholesterol in the liver, it helps prevent the accumulation of fatty deposits in the arteries. Additionally, the medication can slightly increase the levels of High-Density Lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol, which helps remove other forms of cholesterol from the bloodstream.

Triglyceride Reduction

In addition to its effects on cholesterol, Simvastatine is used to treat elevated levels of triglycerides. Triglycerides are a type of fat found in the blood that, when present in high concentrations, can contribute to the narrowing of blood vessels.

Benefits in Cardiovascular Health

Beyond managing lipid profiles, Simvastatine is utilized to reduce the risk of significant cardiovascular events. Its use is common in individuals who have a high risk of heart disease or stroke, regardless of their initial cholesterol levels.

Prevention of Cardiovascular Events

For patients with existing coronary heart disease or those at high risk due to conditions such as diabetes or peripheral vascular disease, Simvastatine is used to:

  • Decrease the risk of heart attacks (myocardial infarction).
  • Lower the likelihood of requiring surgical procedures to restore blood flow to the heart.
  • Reduce the risk of stroke or mini-strokes (transient ischemic attacks).
  • Decrease the necessity for hospitalization due to chest pain (angina).

Long-term Vascular Protection

By managing lipid levels and stabilizing existing plaques in the arterial walls, Simvastatine helps maintain better blood flow throughout the body. This systemic approach helps protect the integrity of the cardiovascular system over time.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Simvastatin

This information is based strictly on regulatory documentation and official government guidance (e.g., FDA, EMA), detailing the population-based rules for its use.


Populations with Absolute Contraindication (Must Not Use)

Simvastatin is formally contraindicated in patients with the following conditions:

  • Active Liver Disease: Patients with active liver disease, including unexplained persistent elevation of liver enzymes.
  • Reproductive Status: Women who are pregnant or breastfeeding.
  • Hypersensitivity: Patients with known allergy to simvastatin or any components of the tablet.
  • Concomitant Drugs: Patients concurrently taking strong CYP3A4 inhibitors (e.g., specific antifungals or antibiotics), or specific medications like ciclosporin, gemfibrozil, or danazol.

Age-Related and Conditional Eligibility

Population Group Regulatory Eligibility Status
Adults Eligible for standard labeled conditions.
Adolescents (10–17 years) Eligible only for specific conditions, such as Heterozygous Familial Hypercholesterolemia (HeFH).
Children (<10 years) Use is not established as safety and efficacy data are insufficient.
Older Adults (65 years) Eligible, but advanced age is listed as a predisposing factor for muscle-related risks, requiring caution.

Restricted and Cautioned Use

  • Highest Dose (mathbf80 mg): This dose is restricted and must not be initiated in new patients. It is only permitted for patients who have been taking the dose chronically (12 months) without evidence of muscle toxicity.
  • Renal Impairment: Patients with severe renal impairment require a lower starting dosage and close monitoring, as defined in official prescribing information.
  • Risk Factors: Individuals with uncontrolled hypothyroidism, a history of muscle toxicity with a statin, or those who consume substantial quantities of alcohol are advised to use the medication with caution due to increased risk of muscle effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Simvastatin's official interaction profile is primarily governed by its metabolism through the enzyme CYP3A4 and its reliance on the transporter protein OATP1B1. Inhibition of these pathways can significantly increase the drug's plasma concentration, leading to specific regulatory restrictions.

Contraindicated Combinations

Co-administration is formally contraindicated with strong CYP3A4 inhibitors, including specific azole antifungals, certain macrolide antibiotics, and HIV protease inhibitors. This restriction also applies to Gemfibrozil, Cyclosporine, and Danazol.

Interaction Type Interacting Substance/Class Regulatory Requirement
Exposure Increase Verapamil, Diltiazem, Dronedarone Maximum daily dose limited to 10 mg
Exposure Increase Amiodarone, Amlodipine, Ranolazine Maximum daily dose limited to 20 mg

Other Documented Interactions

The co-administration of Coumarin Anticoagulants (e.g., Warfarin) with Simvastatin may potentiate their effect, requiring the procedural monitoring of the International Normalized Ratio (INR). Cases of myopathy have been reported when Simvastatin is used concomitantly with Colchicine.

Consumption of Grapefruit Juice (specifically large quantities, defined in labeling as over one quart daily) is restricted due to its inhibitory effect on gut wall CYP3A4, which increases drug exposure. A higher incidence of muscle effects has also been noted in Chinese patients when Simvastatin is co-administered with lipid-modifying doses of Niacin.

Mechanism of Action

Blocking the Core Cholesterol Synthesis Pathway

Simvastatin functions as a prodrug, metabolically converted in the liver to its active form, simvastatin acid. This active metabolite acts as a competitive inhibitor of the enzyme HMG-CoA Reductase, which catalyzes the rate-limiting step within the liver's mevalonate pathway. This molecular action directly blocks the endogenous synthesis of cholesterol in hepatocytes.

⬆️ Enhancing Systemic Lipid Clearance

The resulting depletion of intracellular cholesterol triggers a physiological feedback response that causes the liver to increase the expression and activity of Low-Density Lipoprotein (LDL) Receptors on its surface. This enhanced receptor density increases the liver’s capacity to extract and catabolize LDL-C from the circulating blood. The combined effect of reduced synthesis and enhanced clearance results in a net reduction of circulating atherogenic lipoproteins.

️ Non-Lipid Modulation of Vascular Function

Beyond lipid control, the enzyme inhibition also modulates the production of non-sterol intermediates, such as isoprenoids. This secondary action influences intracellular signaling pathways within the blood vessel walls, including those regulating inflammation. This modulation leads to modification of vascular endothelial function, contributing to downstream physiological changes.

Dosage and Administration Information

How to Use Simvastatin

Simvastatin is designed for oral administration as a conventional tablet and is intended for long-term, continuous therapy. The overarching principle of use is to administer the medication once daily in the evening.

Administration and Timing

The dosage is to be taken once daily, and the standard practice is to take it in the evening or at bedtime. This timing aligns with the body’s natural cycle of cholesterol production. The tablet can be taken with or without food. Proper administration requires the tablet to be swallowed whole and not crushed, broken, or chewed.

Official Dosing Patterns

Treatment is initiated at a low dose and systematically adjusted. Standard adult starting doses are typically 10 mg or 20 mg once daily. Dose adjustments, or titration, should occur no more frequently than at four-week intervals to allow for assessment of response. The usual maintenance dose range is between 5 mg and 40 mg daily. While an 80 mg dose is available, it is not recommended for new patients and its use is subject to specific warnings.

Population and Procedural Rules

Population Group Labeled Use Guideline
Pediatric (Aged 10+) Approved dose ranges from 10 mg to 40 mg daily for specific inherited conditions.
Severe Renal Impairment Dosing may be restricted to a maximum of 10 mg daily.
Missed Dose If a dose is missed, the guidance is to skip it and resume the schedule at the next usual time; do not take a double dose.

This continuous, time-specific protocol defines the standardized approach to using Simvastatin.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Simvastatin

Evidence for the Reduction of Cardiovascular Events

Research has explored outcomes related to serious heart and blood vessel events, such as heart attacks and strokes. These investigations typically involve large-scale, randomized controlled trials (RCTs), where researchers studies explored the difference between groups receiving Simvastatin and control groups, often over intermediate to long-term follow-up periods of several years. The outcomes related to systemic or functional imbalance that were studies monitored include the occurrence of non-fatal heart attacks, the incidence of revascularization procedures (such as angioplasty or bypass), and all-cause mortality. Study populations focused on high-risk adults with established coronary heart disease, as well as individuals with risk factors like diabetes, who have not yet had a major event.

Trials described patterns in the measured incidence of the composite cardiovascular outcome and all-cause mortality between the Simvastatin groups and the control groups. Some large trials reported numerical variations in the measured rate of the composite cardiovascular outcome when comparing the Simvastatin groups to control groups. Research describes the measured rates of cardiovascular events and all-cause mortality, though findings describe group patterns, not personal outcomes.

Evidence for Managing High Cholesterol (Hypercholesterolemia)

Simvastatin was evaluated in research concerning high levels of lipids in the blood, known as hypercholesterolemia. Research in this area involves short-term randomized controlled trials and dose-ranging studies. These studies focus on outcomes monitoring physiological strain or stress, specifically measuring changes in LDL cholesterol, Total Cholesterol, and Triglycerides. The research describes the measured changes in these lipid levels.

However, the evidence primarily provides research provides insight into short-term changes. The follow-up durations were limited in these studies. The relationship between these early measured changes in cholesterol levels and the eventual long-term cardiovascular outcomes is based on extrapolation from the longer cardiovascular event trials.

What Research is Still Unclear or Insufficient

Despite extensive research, what is still uncertain includes the full range of very rare adverse events, which often require long-term, post-marketing observation. Certainty remains low for long-term outcomes extending beyond the follow-up periods of the core RCTs. Follow-up durations were limited for many of the studies that compared Simvastatin to other statin treatments. Research is ongoing to address these evidence gaps.

Frequently Asked Questions (FAQ)

Common questions about Simvastatine (FAQ)


Q: What is the main reason doctors prescribe Simvastatine?

Simvastatine is indicated for the treatment of high cholesterol, known as hyperlipidemia, as an adjunct to diet. Additionally, official product information indicates the medicine is used to reduce the risk of major cardiovascular events, such as heart attacks and strokes.


Q: Is Simvastatine a type of statin?

Yes, Simvastatine belongs to a class of medications called HMG- CoA reductase inhibitors, which are commonly known as statins.


Q: How is Simvastatine different from atorvastatin?

Regulatory guidance describes Simvastatine as being metabolized by a specific enzyme ( CYP3 A4). This particular metabolic pathway makes Simvastatine sensitive to interactions with certain other medications, which can potentially increase the risk of muscle side effects.


Q: Does Simvastatine affect liver function?

Yes, the drug can cause elevations of serum transaminases, which are a type of liver enzyme. For this reason, official product information lists active liver disease as a condition that prevents a person from being eligible to use the medicine.


Q: How long does it usually take to see the effects of Simvastatine?

The official protocol recommends that the effect of the medication be assessed using blood tests to determine lipid levels. These tests are performed as early as four weeks after initiating therapy or adjusting the dosage, suggesting that the full therapeutic effect is not immediate.


Q: Can Simvastatine cause muscle aches?

Yes, muscle pain, tenderness, or weakness (known as myopathy) are known adverse effects listed in official documents. Official safety information indicates that symptoms should be reported to a healthcare professional. The most severe form of muscle toxicity associated with this class of drug is rhabdomyolysis.


Q: What are the most common side effects of Simvastatine that people report?

The most common adverse effects noted in postmarketing experience sections of official documents include headache, abdominal pain, and muscle pain ( myalgia). Other reported issues may include constipation and gastrointestinal distress.


Q: Does Simvastatine interact with grapefruit or grapefruit juice?

Yes, regulatory documents advise that grapefruit or grapefruit juice is typically avoided or contraindicated. Consuming them can significantly increase the concentration of the medicine in the blood, which raises the risk of serious side effects.


Q: Is Simvastatine safe to take if I have diabetes?

Official safety information indicates that statin treatment, including Simvastatine, is associated with a small increase in the risk of developing new-onset diabetes and may potentially worsen blood sugar control in those who already have diabetes.


Q: Can Simvastatine be taken by older adults?

Official prescribing information from regulatory bodies includes specific sections and guidelines for geriatric use (older adults).


Q: Is Simvastatine used to prevent heart attacks or strokes?

Yes, one of the medicine's main indications, beyond treating high cholesterol, is to reduce the risk of cardiovascular events. This specifically includes reducing the risk of non-fatal heart attacks and strokes in patients who are at a high risk.


Q: Do I need to follow a special diet while taking Simvastatine?

Official prescribing information states that the medicine is indicated for use as an adjunct to diet. The diet described is specifically one restricted in saturated fat and cholesterol, along with other non-pharmacological measures.


Q: Why do doctors check my blood when I start taking this medicine?

Blood tests are typically performed to monitor liver enzymes ( transaminases) and creatine kinase ( CK) levels. Changes in these values may signal potential side effects, such as liver dysfunction or muscle problems, allowing for monitoring and assessment.


Q: Is it true that Simvastatine can cause memory problems?

Rare reports of cognitive impairment (such as memory loss, forgetfulness, and confusion) have been associated with statin use. This effect is generally described in official documents as nonserious and reversible upon stopping the medication.


Q: Is Simvastatine a lifelong medication?

Regulatory documents state that the drug is designed for long-term, continuous therapy. This is because the underlying condition it treats, atherosclerosis, is considered a chronic process that often requires ongoing management.


Q: Does Simvastatine interact with blood pressure medicine?

Yes, certain types of blood pressure medications, specifically calcium channel blockers like amlodipine, diltiazem, and verapamil, are listed in official documents. These medicines have interaction precautions or specific dose restrictions with Simvastatine.


Q: Can people who drink alcohol use Simvastatine?

Alcohol consumption may increase the risk of side effects on the liver when combined with the drug, which contributes to the overall liver-related risks associated with the medicine.


Q: Is Simvastatine the same as Zocor?

Simvastatine is the generic name for the active medicine. It is commonly marketed under the brand name Zocor in many regions, meaning they contain the same therapeutic ingredient.


Q: What types of cholesterol does Simvastatine help to lower?

Official documents describe the medicine as working to decrease LDL cholesterol and triglycerides (fats) in the blood, and contributes to an increase in HDL cholesterol.


Q: Is Simvastatine considered a high-intensity or low-intensity statin?

Official guidance suggests that if a patient's cholesterol goals are not met, alternative high-intensity statin treatments may be considered. This indicates that Simvastatine is often not categorized among the highest intensity statin options available.


Q: Does Simvastatine work immediately after taking the first dose?

The full therapeutic effect is not immediate. The official recommendation is to assess the medication's effectiveness using blood tests four weeks or more after starting therapy to allow time for the medicine to stabilize cholesterol levels.


Q: Are women who are pregnant or breastfeeding typically allowed to use Simvastatine?

No, the medicine is contraindicated (not permitted) for use in women who are or may become pregnant. The medication is also not recommended for use during breastfeeding.


Q: What is the connection between Simvastatine and liver enzymes?

Simvastatine may cause elevations of serum transaminases, which are a type of liver enzyme measured in the blood. Monitoring these enzymes may be performed as a safety measure while using the medication.


Q: Can taking Simvastatine cause skin sensitivity or rashes?

Regulatory documents list skin and subcutaneous tissue disorders in postmarketing experience, including reports of rash, itching ( pruritus), and photosensitivity. Photosensitivity means the skin may be unusually sensitive to light.


Q: Is it normal to feel tired when first starting Simvastatine?

Official postmarketing experience includes reports of asthenia (physical weakness or lack of energy) and general feelings of being unwell ( malaise). These are reported as potential experiences when taking the medicine.


Q: Does Simvastatine affect fertility?

Regulatory information states there is no clear evidence that the drug reduces fertility in men or women. However, it is strictly contraindicated during pregnancy.


Q: Is there a generic version of Simvastatine available?

Yes, Simvastatine is widely available as a generic medication. The generic version contains the exact same active ingredient as the brand-name product.


Q: Can Simvastatine interact with herbal supplements like St. John's Wort?

Regulatory documents warn about the risks associated with certain substances that can reduce the drug's effectiveness. Some herbal supplements, such as St. John's Wort, may reduce the medication's concentration in the body, potentially affecting its action.


Q: Why is Simvastatine sometimes prescribed with other cholesterol medicines?

Simvastatine may be prescribed as an adjunct to other lipid-lowering treatments for specific conditions, such as Homozygous Familial Hypercholesterolemia ( HoFH). This is typically done when cholesterol goals cannot be achieved with Simvastatine alone.


Q: What is the likelihood of developing serious side effects from Simvastatine?

Official sources classify the risk of serious side effects, such as rhabdomyolysis (severe muscle damage), as very low. Safety information defines the risk of this serious muscle condition as being around 1.5 cases per 100,000 patients.


Q: Is the purpose of Simvastatine solely for high cholesterol?

No, the medicine is also indicated to reduce the risk of cardiovascular events like heart attack and stroke. These risk reduction benefits are a key purpose of the medicine in addition to treating high cholesterol.


Q: How is the safety profile of Simvastatine generally described?

The safety profile is defined in official Warnings and Precautions sections of regulatory documents. These sections emphasize the specific risks of myopathy/rhabdomyolysis (muscle problems) and liver dysfunction.


Q: Does Simvastatine interact with anti-fungal medications?

Yes, co-administration with certain azole antifungals (such as itraconazole, ketoconazole, and posaconazole) is either a contraindication or requires a specific dose restriction. This is due to the potential for harmful interactions.


Q: What is rhabdomyolysis and is it related to Simvastatine?

Rhabdomyolysis is a rare but serious muscle condition associated with Simvastatine use, which can potentially lead to kidney damage. Official documents contain a warning that muscle pain, tenderness, or weakness should be reported promptly to a healthcare professional.


Q: How do medical authorities classify Simvastatine regarding safety during pregnancy?

Medical authorities classify the drug as contraindicated (not permitted) in women who are or may become pregnant. This classification is based on the mechanism of action that may pose a risk of harm to the fetus.


Q: Does Simvastatine have any effect on blood sugar levels?

Yes, official safety information warns of a potential risk of increased blood sugar levels. This may also include the risk of being diagnosed with new-onset type 2 diabetes mellitus while taking the medication.


Q: Are there any common foods or supplements I should avoid while on Simvastatine?

Official documents advise avoiding grapefruit or grapefruit juice because of the potential for increased drug levels, which is associated with an increased risk of side effects.


Q: Can Simvastatine be used by people with kidney problems?

Official guidelines for patients with severe renal impairment state that a lower maximum dose allowance is typically required. This is a regulatory precaution based on the possibility of the medicine accumulating in the body.


Q: What does the research say about Simvastatine's long-term use?

Clinical studies have examined long-term use, and official information indicates that the drug is associated with reductions in the risk of cardiovascular events, including heart attacks and strokes.


Q: How does Simvastatine affect LDL cholesterol?

Official product information states that Simvastatine works to decrease low-density lipoprotein ( LDL) cholesterol, which is often referred to as 'bad' cholesterol.


Q: What medical conditions prevent a person from being eligible for Simvastatine?

Contraindications listed in regulatory documents include active liver disease (including unexplained persistent elevations of serum transaminases), pregnancy, and breastfeeding. Co-administration with certain medications is also a regulatory reason for exclusion.


Q: Does Simvastatine help raise HDL (good) cholesterol?

Official information states that the drug works to decrease bad cholesterol and fats while also increasing high-density lipoprotein ( HDL) cholesterol, often referred to as 'good' cholesterol. This contribution is part of its overall effect on lipid levels.


Q: Are there different forms of Simvastatine (e.g., tablet, liquid)?

Official regulatory information states that Simvastatine is supplied as a film-coated tablet for oral administration.


Q: What are the main contraindications listed for Simvastatine?

Main contraindications include active liver disease, pregnancy, breastfeeding, and co-administration with certain strong enzyme inhibitor medications ( CYP3 A4 inhibitors). These are serious conditions where use is generally not permitted.

How should Simvastatine be stored and disposed of?

How to Store and Dispose of Simvastatin Tablets

Simvastatin tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from environmental factors that can compromise its stability.


Storage Requirements

Condition Requirement
Temperature Do not freeze; store away from excessive heat.
Protection Keep away from moisture and direct light.
Container Store in a closed container.
Child Safety Keep out of the reach and sight of children.

Disposal Instructions

Unused or expired Simvastatin must be disposed of according to official regulatory guidance. The tablets should not be flushed down the toilet or poured into a drain. Patients should use a medicine take-back program or follow other safe disposal methods as advised by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Simvastatine found in:

A-Z Index: